FDA Set to Approve or Deny MDMA Medication By August 2024

In December 2023, the FDA received a New Drug Application (NDA) to treat Post-Traumatic Stress Disorder (PTSD). But what makes this application unique is the fact that the proposed drug is MDMA, aka “ecstasy.” MDMA is a Schedule I substance under the Controlled...